MedTrace Logo

Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

NCT06790368 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-05-01

No results posted yet for this study

Summary

Observational clinical follow-up to evaluate the safety of immunotherapy for the treatment of hymenoptera venom allergy in real-life conditions. It includes the evaluation of controlled and spontaneous stings. This study will be conducted in Spain (multicentric), multicentric and data will be collected prospectively.

Conditions

  • Allergy, Insect Venom
  • Allergy Insect Stinging
  • Insect Sting Allergy

Interventions

BIOLOGICAL

VENOX

Treatment with allergy vaccine against Vespula spp. (wasp) or Apis mellifera (bee), as per clinical indication.

Sponsors & Collaborators

  • Inmunotek S.L.

    lead INDUSTRY

Principal Investigators

  • Arantza Vega Castro · Hospital Universitario de Guadalajara

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-03-01
Completion
2026-06-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06790368 on ClinicalTrials.gov